Jill Ann Howe Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

LCTX Quotes by TradingView

Jill Ann Howe is Chief Financial Officer of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 25,500 shares of LCTX, which is worth approximately $13,260. The most recent transaction as insider was on Nov 26, 2024, when has been sold 15,000 shares (Common Shares) at a price of $0.59 per share, resulting in proceeds of $8,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.5K
142.86% 3M change
n/a 12M change
Total Value Held $13,260

Jill Ann Howe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 26 2024
BUY
Open market or private purchase
$8,850 $0.59 p/Share
15,000 Added 37.04%
25,500 Common Shares
Aug 16 2024
BUY
Open market or private purchase
$9,345 $0.89 p/Share
10,500 Added 50.0%
10,500 Common Shares

Also insider at

BIOR
BIORA THERAPEUTICS, INC.
JAH

Jill Ann Howe

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LCTX